North America Electrical Stimulation Devices Market Trends and Analysis by 2027

The North Americaelectrical stimulation devices marketis expected to reach US$4,724.0 millionby 2027from US$ 2,302.0 millionin 2019. The market is estimated to grow at a CAGR of 9.6%from 2020 to 2027.

The growth of the market is attributed torise in research activities, growing adoption of electrical stimulation devices, increasing awareness about benefits provided by electrical stimulation, and growingnumber of product launches. However, the high cost of procedureshinders the growth of the market in North America.

The North America electrical stimulation devices market is expected to witness significant growth during the forecast period due to growingprevalence of neurological abnormalities and associated conditions. Several frequently observed neurological diseases comprises narcolepsy, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchenne muscular dystrophy, and others. According to data published by National Institutes of Neurological Disorders and Stroke, in 2019, 7,000 rare neurological diseases were registered in the US. Additionally, according to the same study, these conditions are responsible for significant number of morbidities and mortalities. Such growing prevalence of neurological conditions are likely to drive the North America electrical stimulation devices market by 2027.

US is among the major countries in the electrical stimulation devices market in this region. The growth of USelectrical stimulation devices marketis prominently attributed to increasing adoption of electrical stimulation devices and rising demand for advanced therapeutic platforms to deal with chronic pain. Additionally, rapid technological innovations and collaborations are boosting the electrical stimulation devices marketgrowth in the country.

North AmericaElectrical Stimulation Devices MarketRevenue and Forecast to 2027 (US$ Million)

North AmericaElectrical Stimulation Devices Market Segmentation

By Device Type

• Spinal Cord Stimulation Devices
• Deep Brain Stimulation Devices
• Vagus Nerve Stimulation (VNS) Devices
• Sacral Nerve Stimulation (SNS) Devices
• Gastric Electrical Stimulation (GES) Devices
• Transcutaneous Electrical Nerve Stimulation (TENS) Devices
• Other Devices

By Application

• Pain Management
• Neurological and Movement Disorder Management
• Musculoskeletal Disorder Management
• Metabolism and GIT Management
• Incontinence Management
• Other Application

By Country

• US
• Canada
• Mexico

Company Profiles

• Boston Scientific Corporation
• Medtronic
• Abbott
• BTL
• DJO Global Inc.

North America Electrical Stimulation Devices Report Scope